This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Glucagon-like peptide-1 and dual/triple receptor agonists in the treatment of metabolic dysfunction-associated steatotic liver disease: advances in mechanistic research.
Frontiers in medicine, 13, 1763185
Citation
Lu, Xinyi; Yang, Li. (2026). Glucagon-like peptide-1 and dual/triple receptor agonists in the treatment of metabolic dysfunction-associated steatotic liver disease: advances in mechanistic research.. Frontiers in medicine, 13, 1763185. https://doi.org/10.3389/fmed.2026.1763185